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09-9666/ª 2016 Hellenic Cardiologi
ense (http://creativecommons.org/Pulmonary hypertension (PH) is characterized by high blood
pressure of the pulmonary vasculature and deterioration of
right ventricular function.1 Although not historically pre-
scribed, recent evidence suggests that exercise training
may partially reverse symptoms of muscle fatigue and
dyspnea, improving exercise tolerance and daily life ac-
tivities.2, 3 Furthermore, a decrease in inspiratory muscle
function has been reported when assessed with both voli-
tional and non-volitional tests, which correlated with a
decrease in exercise capacity evaluated by the 6-min
walking test (6MWT).4 However, evidence of the potential
benefits of inspiratory muscle training (IMT) in PH is
limited.5 We hypothesized that IMT could improve inspira-
tory muscle function, dyspnea, exercise capacity and
health-related QoL (HRQoL) in a group of patients with PH.
Patients were included in the study if they were medi-
cally stable and had a confirmed diagnosis of PH based on
elevated pulmonary artery pressure measured by right
heart catheterisation at rest and echocardiography per-
formed by cardiologists who were blind to the study. Pa-
tients (nZ 10) were randomized to an IMT group (IMTG,
nZ 5) or a control group (CG, nZ 5). The IMTG underwent
supervised high-intensity IMT, while patients in the CG didstract of this work was
uroPRevent, Lisbon, Portugal
of Hellenic Cardiological
.05.008
cal Society. Publishing services by
licenses/by-nc-nd/4.0/).not undergo training. Pre- and post-training all patients
were evaluated for inspiratory muscle function, lung vol-
ume, exercise capacity, dyspnea and HRQoL. At baseline
patients’ inspiratory muscle function was compared with
that of 10 normal subjects (NS) randomly assigned from
the hospital staff.
All experimental procedures followed were in accor-
dance with the ethical standards of the responsible com-
mittee on human experimentation (institutional and
national) and with the Helsinki Declaration of 1975, as
revised in 2000. The protocol was approved by the Hospital
Ethics Committee, and written informed consent was ob-
tained from all subjects prior to study entry.
Measurements of maximal inspiratory pressure (PImax)
and inspiratory work capacity (sustained maximal inspira-
tory pressure, SPImax) were made using an electronic pres-
sure manometer and computer software (Trainair, Project
Electronics Ltd., London, U.K).6 Dynamic lung volumes
were measured in the sitting position using a Jaeger system
(Masterlab, Jaeger, Wuerzberg, Germany). Exercise ca-
pacity was assessed with the 6MWT and dyspnea with the
Borg scale (0-10) at the end of the 6MWT. HRQoL was
assessed by the Short Form Health Survey (SF36v2) ques-
tionnaire, which consists of 36 items representing 8 sub-
scales that cover the domains of physical functioning (PF),
role physical (RP), bodily pain (BP), general health (GH),
vitality (VT), social functioning (SF), role emotional (RE),
mental health (MH) and reported health transition (HT).7
IMT was performed with an inspiratory-incremental resis-
tive loading device as previously described (Trainair,
Project Electronics Ltd, U.K). 6, 8 Patients in the IMTG were
exercised at 60% of individual SPImax for 30 min, 3 times a
week for 10 weeks in the hospital.
All continuous variables are expressed as the mean -
 standard deviation of the mean (m SD). Baseline com-
parisons between groups were performed using Student’s t-
test and the chi-square test. The paired t-test was used to
assess training-induced changes (pre vs. post) within a
particular group and the repeated measures analysis of
variance (RMANOVA) for between groups. Statistical ana-
lyses were performed using SPSS software (version 18, SPSS
Inc., Chicago, Illinois, USA).Elsevier B.V. This is an open access article under the CC BY-NC-ND
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groups did not differ significantly in their demographic and
clinical characteristics (Table 1). Patients and NS were also
matched for gender (PH, males/females, 4/6 vs. NS, males/
females 5/5, pZ ns), age (PH, 54.6 13.4 vs. NS,
53.8 8.4 yrs, pZ ns) and body mass index (PH, 26.4 4.7
vs. NS, 28.1 3.3, kg/m2, pZ ns). Both PImax and SPImax
were significantly reduced in patients with PH compared
with NS (PH, 68.5 14.4 vs. NS, 101.3 7.6, cmH2O,
p< 0.001), (PH, 282 60 vs. NS, 596 28, cmH2O/s/103,
p< 0.001), respectively. The IMTG increased significantly
PImax (94.4  16.8 vs. 63.8  16.9 cmH2O, p Z 0.004) and
SPImax (412.8  38 vs. 261.6  63 cmH2O/s/103, pZ 0.009),
while in the CG no significant changes were detected in
PImax (71.4  11.3 vs. 73.2  11 cmH2O, pZ ns), or SPImax,
(302  61 vs. 300  56 cmH2O/s/103 pZ ns). No significant
changes were shown in dynamic lung volume evaluated byTable 1 Demographic and clinical characteristics of patients a
IMTG (nZ 5)
Age (yrs) 48.6 12.7
Gender Males (1)/Females (4)
BMI (kg/m2) 28.3 4.2
WHO (I-IV) functional class 2.6 0.5
SPAP (mmHg) (invasive) 76.6 30.8
RVSP (mmHg) (echo) 81.4 22
Aetiology Group I (nZ 5)
Medication
ERA 2
PDE-5I 1
Prostanoids 1
Anticoagulants 3
Diuretics 2
Antidepressants 1
CCB 2
IMTG, inspiratory muscle training group; CG, control group; BMI, body
ventricular systolic pressure; Group I (idiopathic nZ 2, associated with
ventricular septum defect nZ 1, portal hypertension nZ 1) and Grou
antagonist; PDE-5I, phosphodiesterase-5Inhibitors; CCB, calcium chan
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Figure 1 Quality of life questionnaire recordings pre-and post- f
group (CG). PF, Physical Functioning; RP, Role-Physical; BP, Bodily P
Role Emotional; MH, mental health; HT, Reported Health Transitiospirometry for any of the groups. Patients in the IMTG
increased their 6MWT distance (436 95 vs. 391 94 m,
pZ 0.008) with less dyspnea (Borg scale, 2 1 vs.
4.2 1.9, pZ 0.03). No significant changes were noted in
the CG ([6MWT, 376 109 vs. 384 117 m, pZ ns]; [Borg
scale, 3.6 1.3 vs. 3.8 1.3, pZ ns]). IMTG significantly
improved the SF36v2 questionnaire (pZ 0.004) as well as
the subscales of the physical component PF (pZ 0.001), RP
(pZ 0.002), the subscale of the mental component SF
(pZ 0.03) and the HT (pZ 0.01). No significant changes
were found in the CG (Figure 1). A between-groups analysis
did not reveal significant differences for any of the pa-
rameters tested.
Thus, IMT resulted in an improvement in inspiratory
muscle indices associated with benefits in walking distance,
dyspnea and HRQoL in PH patients, confirming our hy-
pothesis. Our findings are very encouraging, since previoust baseline.
CG (nZ 5) p
60.6 12.4 ns
Males (3)/Females (2) ns
24.5 4.9 ns
2.4 1.1 ns
90 28 ns
93.2 27 ns
Group IV (nZ 3), Group I (nZ 2) ns
ns
3
2
0
3
1
1
0
mass index; SPAP, systolic pulmonary artery pressure; RVSP, right
scleroderma nZ 2, pulmonary venous obstruction disease nZ 1,
p IV (chronic thromboembolic nZ 3); ERA, endothelium receptor
nel blockers
ubscales
IMTG
CG
SF (p=0.03)
RE MH
HT (p=0.01)
or the inspiratory muscle training group (IMTG) and the control
ain; GH, General Health; VT, Vitality; SF, Social Functioning; RE,
n.
Letter to the Editor 291studies also report benefits of exercise training in patients
with PH 2, 3 and are in agreement with recent findings of an
IMT-induced improvement in the functional capacity of this
population 5. Inspiratory muscle function was also found to
be reduced in patients with PH compared with normal
subjects. The reasoning behind this decrease has not been
investigated thoroughly until now. Potential reasons
include, similarly to left heart failure, peripheral muscle
myopathy and/or decreased perfusion of the respiratory
muscles resulting in muscle fiber transformation and
atrophy. Furthermore, muscle weakness together with a
correlation between limb and inspiratory muscle strength
have been reported in patients with PH, suggesting gener-
alized myopathy.9
Respiratory muscle weakness could contribute to
impairment in ventilatory capacity and dyspnea 10 and thus
to a decrease in exercise capacity. Improvement in inspi-
ratory muscle function was associated with an improve-
ment in exercise capacity in our patients and most
importantly in their QoL. Factors that may lead to impaired
QoL in patients with PH include dyspnea, functional limi-
tations, adverse effects of therapy, social isolation, and
emotional issues such as anxiety and depression. 11 In this
study, we have shown that supervised IMT in PH patients
provides beneficial psychological and physical effects. We
have previously shown that IMT improved inspiratory mus-
cle indices and functional status of left heart failure
petients.6 It is clear that this is a pilot study limited by the
small patient number. However, our findings may stimulate
initiation of further studies in a larger cohort of patients.
Patients with PH appear to have weaker inspiratory
muscles compared with healthy subjects. IMT shows promise
as a safe and potential adjunct therapy in these patients,
improving dyspnea, exercise capacity and life quality.
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